Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer

Adjuvant chemotherapy with gemcitabine is the standard treatment in Japan for patients who have undergone resection of pancreatic cancer. However, few reports have described suitable regimens for patients who present cancer relapse following adjuvant chemotherapy. In the present study, we retrospect...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: ISHIDO, KEINOSUKE, TOYOKI, YOSHIKAZU, KUDO, DAISUKE, KIMURA, NORIHISA, YAMANA, DAISUKE, MIURA, TAKUYA, TSUTSUMI, SHINJI, MUROYA, TAKAHIRO, YOSHIKAWA, TORU, OGASAWARA, HIROSHI, YONAIYAMA, SHINNOSUKE, NARUMI, SHUNJI, HAKAMADA, KENICHI
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2011
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3406543/
https://ncbi.nlm.nih.gov/pubmed/22848308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.412
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller